From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Letter to AIM Regulation: Regarding Advanced Oncotherapy you are now taking the piss: Rules are rules aren’t they?

By Tom Winnifrith | Wednesday 31 January 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I am not talking about imaginary rules dreamt up by the wretched poltroon Giles Balleny at Cavendish and the bearded buffoon Stuart Ashman but real AIM Rules, specifically the one that if shares are suspended for more than six months because of a failure to publish accounts, those shares are slung off AIM. But sometimes they are not. I have written to the Oxymorons at AIM regulation regarding Advanced Oncotherapy (AVO), where I own 1 share allowing me to attend AGMs but have been a perennial bear.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Black-Swan

Video: Poking Bears And Black Swans

 

SBTX

Is Stuart Ashman lying again?

 

Crime-Scene

So farewell then MichaelWalters.com

Time left: 09:43:07